Medical News | Hyperlipidemia - ModernMedicine

Hyperlipidemia

Editor's Choice
Emerging risk factors and risk markers for cardiovascular disease: Looking beyond NCEP ATP III
This review discusses emerging risk factors for CVD, including hs-CRP, lipoprotein(a), homocysteine, fibrinogen, homocysteine, and coronary artery calcification.
LATEST ARTICLES
Statins and cancer: Discovering their role in treating gynecologic cancers
HMG-CoA reductase inhibitors, commonly referred to as statins, have gained popularity for their ability to effectively lower cholesterol levels in patients with CV disease, but new roles for statins may be on the horizon.
First visit of a 47-year-old woman with severe hypertriglyceridemia and type 2 diabetes (CME)
First visit of a 47-year-old woman with severe hypertriglyceridemia and type 2 diabetes
Second visit of a 47-year-old woman with severe hypertriglyceridemia and type 2 diabetes (CME)
Second visit of a 47-year-old woman with severe hypertriglyceridemia and type 2 diabetes
Emerging risk factors and risk markers for cardiovascular disease: Looking beyond NCEP ATP III
This review discusses emerging risk factors for CVD, including hs-CRP, lipoprotein(a), homocysteine, fibrinogen, homocysteine, and coronary artery calcification.
Elevated CRP alone doesn't justify statin treatment
C-reactive protein (CRP) doesn't add predictive value to traditional cardiovascular risk factors, and there does not appear to be a causal association between CRP and coronary heart disease (CHD), according to results of two studies published in the July 1, 2009, issue of the Journal of the American Medical Association.
eSamples check closet
eSamples check closet
Practice ToolsPractice Tools
Coding Counselor
Coding Counselor

Simple and accurate ICD-9 code search. Start Here

Patient Education
Patient Education

Print customized patient education handouts. Start Here

Surgical Video Center
Surgical Video Center

On-demand surgery demos and presentations. Start Here



Click here